Trial Profile
An fMRI-study on the Effects of 3'-Aminomethylnicotine-P. Aeruginosa r-Exoprotein a Conjugate Vaccine (NicVAX) and Placebo on Central Nervous System Activation and Behaviour Following a Nicotine Challenge
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Mar 2013
Price :
$35
*
At a glance
- Drugs Nicotine abuse vaccine (Primary)
- Indications Smoking withdrawal
- Focus Pharmacodynamics
- 25 Mar 2011 New trial record